MRK

Merck & Co., Inc.

118.95

USD

MRK Earnings Reports

Positive Surprise Ratio

MRK beat 34 of 40 last estimates.

85%

Next Report

Date of Next Report

Apr 30, 2026

Estimate for Q1 26 (Revenue/ EPS)

$16.06B

-$1.36

Implied change from Q4 25 (Revenue/ EPS)

-2.07%

-165.07%

Implied change from Q1 25 (Revenue/ EPS)

+3.42%

-161.26%

Merck & Co., Inc. earnings per share and revenue

On Feb 03, 2026, MRK reported earnings of 2.09 USD per share (EPS) for Q4 25, beating the estimate of 2.02 USD, resulting in a 2.98% surprise. Revenue reached 16.40 billion, compared to an expected 16.35 billion, with a 0.31% difference. The market reacted with a +2.18% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 12 analysts forecast an EPS of -1.36 USD, with revenue projected to reach 16.06 billion USD, implying an decrease of -165.07% EPS, and decrease of -2.07% in Revenue from the last quarter.

FAQ

What were Merck & Co., Inc.'s earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Merck & Co., Inc. reported EPS of $2.09, beating estimates by 2.98%, and revenue of $16.40B, 0.31% above expectations.

How did the market react to Merck & Co., Inc.'s Q4 2025 earnings?

The stock price moved up 2.18%, changed from $113.37 before the earnings release to $115.84 the day after.

When is Merck & Co., Inc. expected to report next?

The next earning report is scheduled for Apr 30, 2026.

What are the forecasts for Merck & Co., Inc.'s next earnings report?

Based on 12 analysts, Merck & Co., Inc. is expected to report EPS of -$1.36 and revenue of $16.06B for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.